Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

 

3. NxStage Medical wins FDA nod for nocturnal home dialysis

NxStage Medical said today that it won 510(k) clearance from the FDA for nocturnal home hemodialysis treatment using its System One device.

The Lawrence, Mass.-based company said the System One is the only hemodialysis device cleared in the U.S. for nocturnal treatments. NxStage said it plans to begin marketing for the expanded indication in 2015. Read more

2. Diabetes: Asante Solutions registers for $45m IPO

Asante Solutions registered for a $45 million initial public offering for its modular Snap insulin pump, which is designed to use pre-loaded insulin cartridges.

The Sunnyvale, Calif.-based company, which 1st filed a confidential registration with the SEC last October, said it plans to list on the NASDAQ exchange under the PUMP symbol. Read more

1. 2014 in review: Changes at the top for medical device companies

There was a revolving door on medtech’s corner office this year, with more than 35 CEOs leaving their positions through planned transitions, retirement or termination, according to a MassDevice.com analysis.

Although there’s some transition at the top every year, 2014 was notable for a few dramatic exits by some big names, including David Pyott, the longtime chief executive at Allergan. Read more